NCT03595891已完成不适用
Apixaban Length-Of-Stay Pulmonary Embolism Study - Hospital Admissions (ALPHA-PE)
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 660 人开始时间: 2017年1月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 660
- 试验地点
- 1
- 主要终点
- Compare the average length of stay in secondary care
研究概览
简要总结
A study based on a chart review of participants that presented with a sudden blood clot in the lung
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults participants at date of admission
- •Primary presentation consistent with PE followed by objectively-confirmed acute PE
- •Received anti-coagulation upon diagnosis of PE during study period and in receipt of anti-coagulation at discharge
排除标准
- •PE diagnosed during a hospital admission for a reason other than PE during the study period
- •Patients receiving anticoagulation at the time of presentation
- •Patients presenting outside the defined study period
- •Other protocol defined inclusion/exclusion criteria could apply
结局指标
主要结局
Compare the average length of stay in secondary care
时间窗: 60 days
次要结局
- Distribution of clinical characteristics of patients admitted with a PE(Baseline)
- Distribution of demographic data of patients admitted with a PE(Baseline)
- Total length of stay, including repeat admissions(During the first 30 days after presentation of PE)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryDeep Vein ThrombosisPulmonary EmbolismNCT00452530Bristol-Myers Squibb3,221
终止
4 期
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary EmbolismPulmonary Embolism With Acute Cor PulmonalePulmonary Embolism With Pulmonary InfarctionPulmonary Embolism Subacute MassiveRight Ventricular DysfunctionRight Ventricular FailurePulmonary EmbolismNCT03988842Victor Tapson, MD4
已完成
3 期
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical IllnessVenous ThrombosisPulmonary EmbolismNCT00457002Bristol-Myers Squibb6,758
已完成
3 期
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic TransformationStrokeAtrial FibrillationTransient Ischemic AttackNCT02283294University of South Florida91
已完成
3 期
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryDeep Vein ThrombosisPulmonary EmbolismNCT00371683Bristol-Myers Squibb3,608